Objective-Patient-centered approaches to improving medication adherence hold promise, but evidence of their effectiveness is unclear. This review reports the current state of scientific research around interventions to improve medication management through four patient-centered domains: shared decision-making, methods to enhance effective prescribing, systems for eliciting and acting on patient feedback about medication use and treatment goals, and medication-taking behavior.
Introduction
Nearly 70% of Americans are prescribed at least one prescription drug, and 20% use five or more [1] . Medications have become a central component of the treatment of many diseases; however, 20% to 30% of prescriptions are never filled, and of those prescriptions that are filled, roughly half are not taken as prescribed [2] . These gaps in adherence result in an estimated $100 billion to $290 billion annually in avoidable health care costs [3] [4] [5] [6] . Patients do not take prescribed medications for many reasons, including poor prescribing practices that create burdensome and complex regimens, concerns about cost and side effects, doubts about the benefit of medications, and low health literacy [7] .
Interventions have attempted to increase medication adherence and related outcomes using a variety of approaches. Recent reviews of this literature found that the most effective medication adherence interventions adopted comprehensive approaches, involved several strategies, were high-intensity, and were tailored to individual patients [8] [9] [10] . However, these reviews also noted the low strength of evidence for many interventions and a need for more research to establish value and show improvements in health outcomes as a result of improved adherence [8] [9] [10] . Patient-centered approaches may represent a foundation upon which to develop new medication adherence interventions and enhance those that exist, but with the intent of also improving clinical outcomes, patient experience, and satisfaction with medication use.
The Agency for Healthcare Research and Quality (AHRQ)-funded Centers for Education and Research on Therapeutics (CERTs) program conducts research and provides education to advance the optimal use of drugs and medical devices, and biological products; increase awareness of the benefits and risks of therapeutics; and improve quality while cutting the costs of care. In 2012, the CERTs focused on how patient-centered care could be incorporated into efforts to improve medication management and related outcomes among chronically ill patients. This initiative culminated in a workshop that brought together patients, providers, researchers, and other stakeholders to identify innovations, successes, and needs in the research and implementation of strategies to improve medication management through patient-centered approaches (McMullen, 2013 , submitted in parallelcitation forthcoming). These approaches included four domains of the medication management process: shared decision-making, methods to enhance effective prescribing, systems for eliciting and acting on patient feedback about medication use and treatment goals, and support for medication-taking behavior (the traditional scope of adherence domains were reflective of a continuous process for the management of prescribing and medication-taking and, thus, were overlapping. Therefore, although we could identify interventions based on the framework, we found it difficult to categorize interventions into mutually exclusive groups based on the framework. To account for difficulty in the application of the framework and to provide structure to the discussion of results, interventions were categorized by the primary intervention type or approach through which researchers sought to impact the steps outlined in the PCMM framework. These intervention types were informed by the expertise of the steering group, are similar to intervention types reported in previous reviews of medication adherence interventions, and were collected as part of the abstraction process. We report interventions categorized into the following intervention types: (1) educational interventions, (2) augmented pharmacy services, (3) decision aids or shared decision-making, (4) case management, and (5) pharmacist or physician access to adherence or clinical outcome information and monitoring of medication-taking behaviors (i.e., feedback interventions).
We examined whether interventions focused on adherence, clinical, or patient-centered outcomes. Adherence measures varied widely, and included rates measured through prescription fills, pill counts, electronic monitoring, medication possession ratio (MPR), as well as self-report medication adherence scales. Clinical outcomes included measures that indicate a patient's disease status, such as cholesterol levels, depression symptom scores, or blood glucose levels. While alleviation of clinical symptoms, improvement in disease status, and successful adherence to medication regimens are clearly important to patients, for the purposes of this review, we defined a patient-centered outcome as an outcome of importance to patients but not inclusive of adherence or clinical measures (e.g., blood pressure). Examples of these outcomes included patient knowledge, quality of life, satisfaction, perceived control of symptoms, self-efficacy, understanding of treatment benefits and risks, and perceived barriers to medication use. We included hospitalization, mortality, and cost outcomes separately. We then qualitatively summarized the characteristics and outcomes of these interventions.
Although we collected data to describe the impact of interventions, study methodologies, outcome measurement, populations studied, and clinical focus, the studies were too heterogeneous to perform a formal meta-analysis. Thus, quantitative comparisons of effect sizes and discussion comparing study design and measurement methodology were outside the scope of this paper.
Results

Results of literature search
Using our search strategy, we identified 536 citations; manual searches of systematic reviews and other sources added 65 citations (Figure 1 ). After screening abstracts for eligibility and exclusion criteria, we reviewed 133 full-text articles. Following full-text review, 60 articles represented unique studies and were included. Of those, 43 were individual or cluster-randomized controlled trials, four were pragmatic trials, and 13 employed quasi-experimental study designs. Seven of the 13 quasi-experimental studies utilized a before-and-after design methodology, while the remaining six studies employed interrupted time series or other retrospective designs.
Description of Interventions and Impact on Outcomes
Interventions were categorized by the primary intervention type, as follows: (1) educational interventions delivered with or without additional behavioral or social support [13- (Table 3) ; (4) case management [60] [61] [62] [63] [64] [65] [66] [67] (Table 4) ; and (5) feedback of adherence or clinical values to pharmacists or physicians or monitoring of medication-taking behaviors [68] [69] [70] [71] [72] (Table 4 ).
Interventions were delivered by a diverse group of professionals and, in many cases, more than one health care professional. Physicians, pharmacists, and multidisciplinary teams delivered interventions in 14, 12, and 11 studies, respectively. Physicians most often delivered decision aids, shared decision-making interventions, and educational interventions. Pharmacists were the only health care professionals to engage patients in augmented pharmacy services. The clinical conditions most frequently targeted by these interventions were cardiovascular diseases-including hypertension, atrial fibrillation, and heart failure. Other commonly targeted illnesses included diabetes and asthma. Time for patient follow-up after the intervention ranged from one-time measurements to five years, with a median duration of six months.
Nearly all of the studies evaluated the impact of the intervention on more than one outcome, although medication adherence was assessed most commonly, in 43 of the 60 studies. Studies also focused on patient-centered outcomes such as quality of life, patient knowledge, and patient satisfaction (34 studies); clinical outcomes including measures of disease status such as blood pressure, cholesterol levels, and depression symptom scores (26 studies); hospitalization or mortality outcomes (nine studies); and medication utilization (eight studies) or cost to patients or health plans (five studies).
Patient education interventions-Educational interventions provided
information to patients about already prescribed medication regimens and often resulted in better medication adherence and greater patient knowledge. The benefits of these interventions were most evident in their impact on patient-centered outcomes such as patient knowledge, self-efficacy, and self-monitoring skills. The most successful educational interventions combined patient education with efforts such as coaching or behavioral and social support.
Twenty-six of the 60 studies reported on educational interventions, with or without additional components such as behavioral or social support ( Table 1 ). The majority of these interventions (16 of 26 studies) focused on medication-taking [13;17-20;23-28;30;31;34;36;37] , while five addressed effective prescribing [16;22;29;35;38] , four utilized shared decision-making [14;15;32;33] , and one addressed effective feedback [21] . Educational interventions were frequently delivered by research personnel or multidisciplinary teams. These interventions were commonly repetitive and occurred over varied periods of time, ranging from weeks to years, making comparison difficult.
Sixteen of the 26 educational intervention studies examined medication adherence as an outcome. Patients receiving education typically had higher adherence rates than patients receiving usual care. However, in a number of studies, the intervention produced no significant long-term impact on adherence when compared to patients not receiving the intervention [19;23;25;31;35] . For example, Pladevall et al. reported a 30% increase in medication adherence following education supplemented by adherence monitoring and provision of social support, although the control group also improved adherence by 20% and both groups attained approximately 90% adherence upon study completion [25] . Several studies reported diminishing adherence rates over study follow-up. For example, in one study, patients who participated in group educational meetings had a 26% decrease in adherence over the course of study follow-up. However, in the same study, patients who received education on an individual basis experienced a similar 25% decline in adherence [14] . In fact, a number of studies noted that significantly higher adherence rates among intervention versus control patients were attributed only to a slower decline in adherence over time among intervention patients [14;23;24;27;31].
Patient-centered outcomes were measured in 14 educational interventions, with 11 studies reporting significant improvements in one or more of these outcomes. Four studies reported adherence improvements as well as increased patient knowledge, self-efficacy, and selfmonitoring skills; reductions in barriers to adherence; and greater patient activation [20;24;27;33] . Notably, for these outcomes, successful interventions combined patient education with supplemental coaching, motivational approaches, or social support.
Seven of the nine educational intervention studies that measured clinical outcomes found significant improvements in the management of diabetes [13;33;35] , hypertension [17;25] , mental health among rheumatoid arthritis patients [26] , and fracture risk among osteoporosis patients [37] . Two studies examined hospitalization among hypertensive patients; one of these studies resulted in decreased hospitalization [21] , while one did not [19] , despite having interventions that were relatively similar in intensity. Finally, only one of four studies to examine mortality outcomes found a significant survival benefit [28] .
Six studies provided insight into resource investment and patient selection associated with educational interventions. Homer et al. found that the provision of information in group settings rather than on an individual basis led to better adherence and lower rates of drug discontinuation, while using fewer health care resources and incurring lower costs to patients and health plans [14] . In other studies, authors noted that educational interventions might be most cost-effective among less-adherent populations [19] and most effective in improving outcomes among patients with an acute event [13] , patients with a shorter time since diagnosis and initial prescribing [26] , patients with high health literacy [26] , and patients who are "ready for change" [33;37]. However, the lack of consistency among the studies in design and measures limits the ability to draw general conclusions about subgroup-specific effectiveness and cost savings.
3.2.2.
Augmented pharmacy services interventions-Augmented pharmacy services studies commonly targeted medically complex patients, identified barriers to already prescribed medication use, and documented effects on outcomes after initial treatment decisions were made. The benefits of these interventions were most evident in the tailoring of medication regimens to ongoing patient needs and in cost reduction. Many pharmacy interventions were tailored to specific patient needs and delivered by pharmacy staff on a one-on-one basis; however, patient-centered outcomes were rarely measured.
Augmented pharmacy services interventions primarily targeted elderly patients with multiple comorbid conditions who were taking several medications ( Evidence supporting the interventions' effectiveness in improving medication adherence was mixed, although significant positive changes [41;45-48;50] were observed more often than negative or non-significant findings [39;42]. Patient-centered outcomes were less likely to be measured than clinical or adherence outcomes following pharmacy interventions; however, when assessed, patients were often satisfied with their interactions with pharmacists and with potential cost savings. Overall, patient cost and utilization outcomes were measured following augmented pharmacy services more frequently than for any other type of intervention. There appeared to be a trend toward reduced costs to patients [39;44;47;48;50]; however, Welch et al. reported increased medication costs following a medication review and counseling intervention [49] . Welch et al. noted that addressing important safety issues such as drug-drug interactions, identification of medication gaps, and under-treatment resulted in improvements in medication regimens and patient adherence; however, patient costs also increased [49] . In contrast, Pindolia et al. reported reductions in total prescriptions per patient per month and reduced pharmacy costs after implementing an intervention that invested only 2.5 hours of telephone contact per patient [48] . Longer-term costs may have been lowered through improved treatment but were not assessed in these studies.
Decision aids and shared decision-making interventions-
We found that decision-making interventions most closely fit the paradigm of patient-centered care. These interventions were implemented at the time of prescribing and often resulted in increased patient knowledge, although there was little evidence for impact on ongoing decisionmaking or improvements in adherence or clinical outcomes.
Nine studies employed decision aids or shared decision-making (SDM) as the principal component of their interventions (Table 3) . [51] [52] [53] [54] [55] [56] [57] [58] [59] . These interventions were most often delivered by physicians during face-to-face health care encounters and were designed to provide patients with information about potential treatment choices and their associated benefits and risks.
Decision aid and SDM interventions are typically designed to inform choice rather than change behavior [55;58] . Accordingly, the measurement of patient knowledge was common (eight of the nine studies) and improvements were noted in seven studies [51-56;58] . Three studies measured and showed improvements in patient participation, confidence in decisionmaking, and satisfaction with care [53;54;56]. Three studies reported that patients' understanding of risk was improved and decisional conflict lessened [52;54;55]. However, authors observed that increased patient knowledge did not change the patient decisionmaking process, and there was little evidence that treatment choice or patient beliefs changed even when patients were more informed about benefits and risks [52-55;57;58] . This suggests that patients may have a wide range of considerations when making treatment decisions, not just medical facts; however, these studies did not report on the range of considerations or the basis for patient decision-making. 
Case management interventions-Case management interventions commonly
employed individualized assessments of patient barriers to medication-taking and tailored approaches to address these barriers. However, the limited number of studies and the wide variation in both the approaches used and resources dedicated to these interventions make it difficult to draw any conclusions about overall effectiveness.
In eight case management intervention studies (Table 4) , nurses and care teams delivered the intervention. Four of eight studies focused on medication-taking [60;61;66;67] , three studies focused on effective feedback [62] [63] [64] , and one focused on effective prescribing [65] . Case management interventions targeted patients with a wide variety of clinical conditions. All studies that measured adherence found either significant improvement in adherence among patients who received the intervention [60-62;65;67] . In addition, four of eight case management studies examined clinical outcomes; all four of these resulted in significant improvements [60;61;64;66] . Last, two case management studies measured quality of life and found no effect [60;63] .
Feedback interventions-These interventions intended to utilize feedback to
foster further discussion of current treatment regimen with the patient as a means to inform changes to these regimens. Five studies provided pharmacists or physicians with information regarding patient medication adherence and clinical status through health information technology, direct patient report, or medical record review (Table 4) . Of these interventions, two focused on effective feedback [68;71] , two concentrated on medication-taking behavior [70;73] , and one centered on effective prescribing [69] . Interventions employing feedback and access to medication adherence information were most commonly conducted among patients with hypertension [70;71] or patients undergoing care for psychiatric illness or depression [68;69;72] . Two of the five studies showed an increase in patient satisfaction regarding care and concordance between patient preferences and prescribed regimens [69;72] . Wilder et al. found that psychiatric patients were more likely to adhere to medications if they received treatments that they preferred, thus underlining the importance of patient preference in medication decision-making and effectiveness [69] .
Discussion and Conclusion
Discussion
Our review describes the extent to which current medication management interventions incorporate elements of patient-centeredness. Our use of the PCMM framework as a guiding principle allowed us to include a wide range of interventions targeting diverse outcomes. However, we found it difficult to meaningfully and consistently categorize interventions into mutually exclusive groups based on the framework's domains, because they are overlapping: shared decision-making, effective prescribing, effective feedback, and medication-taking behavior. This suggests that our framework may better serve as a template for improving how providers and patients engage in medication management than as a structure for studying this process in the scientific literature. In addition, the studies were heterogeneous and results were difficult to collectively interpret. Thus, we could not draw firm conclusions as to whether patient-centered medication management interventions represent a distinct shift away from or an improvement over more traditional medication adherence interventions. Rather, we provide a broad description of interventions, the approaches they took to engage patients, and their contribution to the improvement of outcomes, with the intent of informing the development of future efforts.
A number of comprehensive reviews of medication adherence interventions have been published. A recent evidence review found that a variety of interventions led to adherence improvements, with interventions to reduce out-of-pocket expenses, case management, and educational interventions the most effective across clinical conditions [8] . The authors noted that the majority of efforts to improve adherence did not examine patient-reported outcomes, and when better adherence was observed, there was little evidence of improvement in patients' health outcomes [8] . Our review generally supports this view.
Our review was different from previous reviews because we focused on patient engagement and patient-centered approaches, allowed for observational study designs, and included patient-centered outcomes. Patient knowledge, patient satisfaction, and quality-of-life outcomes were the most commonly-included patient-centered outcomes and were measured in 34 of the 60 articles reviewed. However, additional concepts central to the process of patient-centered care, such as preference for treatment regimens and patients' health care goals, were rarely reported. This may be due to difficulties in measuring these processes and outcomes, such as the lack of widely applied and validated methods. Although all of the included interventions were deemed to be patient-centered, the most common focus was still medication adherence. A variety of interventions observed improvements in adherence over the follow-up period; however, since average follow-up was less than one year, we do not know the optimal length of time over which an intervention should be implemented or the sustainability of intervention effects over time. In turn, there were inconsistent results for a link between adherence and clinical outcomes improvement.
Interventions were delivered by a diverse group of health care providers, either by individuals or as part of collaborative or coordinated care. Many interventions were carried out at one level within a health care visit or setting (e.g., augmented pharmacy services, decision aids, or shared decision-making interventions), despite recognition of the importance of collaborative or coordinated care in the medication adherence literature. For interventions that did incorporate collaborative care, the participation of personnel not otherwise present in the health care system (e.g., study personnel) was common, thus limiting their generalizability.
We found that many studies included small patient samples with very specific clinical and therapeutic needs. Small sample sizes may be due to the high level of tailoring required or the difficulty in systematically developing and carrying out individualized interventions. Furthermore, with the exception of augmented pharmacy services interventions, patients with complex medication needs were often excluded, reducing the potential "real-world" applicability. In addition, many efforts were likely expensive, although details of cost and time commitment were not commonly reported; in most cases, the impact on health careprovider time and the complexity of coordination would also limit generalizability. Finally, interventions were implemented with a focus on specific aspects of medication management; studies did not typically address medication management starting at the prescribing decision and extending to appropriate medication-taking behavior. Thus, combinations of these interventions may be needed to provide long-term impacts on patient outcomes.
Our review has a number of limitations. We based our literature search on our PCMM framework, which was informed by the Institute of Medicine's definition of patient-centered care. We also identified previously published reviews and search strategies that attempted to ascertain patient-centeredness within the scientific literature. Despite these efforts, since the concept of patient-centered care is relatively new and continuously evolving, we may have missed relevant articles.
In addition, we included studies from different populations and clinical settings, with different disease emphases, and differing methodology and measurement. Thus, quantitative comparisons of effect sizes and discussion comparing study design and measurement methodology were outside the scope of this paper. Finally, our summary may suffer from publication or reporting bias, as we found few articles that reported negative results for all outcomes measured.
Conclusions
Our review identified efforts to involve patients in medication prescribing and use. Evidence supporting overall effectiveness of interventions was sparse. Furthermore, there was limited evidence of improved patient-centered outcomes or clinical endpoints and sustained improvement in outcomes. Variability in the delivery of interventions and outcomes measured precluded concrete comparisons between interventions or comparisons with traditional medication adherence interventions. In general, it is not clear that patientcentered medication management interventions represent an improvement over more traditional medication adherence interventions.
Practice Implications and future research
Additional research is needed to examine how to integrate patient-centered care into medication management. This requires the development of definitions and methods to standardize the measurement of adherence and patient-centered outcomes, to allow for comparisons of interventions. Also, future study teams may want to consider incorporating qualitative research methods to provide detail regarding how patient-centered care is delivered and how patient-centeredness is perceived and received by patients. Finally, we encourage additional research within different populations with different clinical needs, that assesses the effectiveness of specific intervention types as well as combinations of intervention types, and that assesses the resources needed to address both initial and chronic medication management issues. These efforts would help foster the identification of effective and feasible approaches to incorporate patient-centeredness into the medication management processes of the current health care system, if appropriate.
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